NR1D2 (Nuclear Receptor Subfamily 1 Group D Member 2)

📖 Wiki Page

gene1597 wordssynced 2026-04-02

NR1D2 (Nuclear Receptor Subfamily 1 Group D Member 2)

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">NR1D2</th></tr>
<tr><td colspan="2" style="text-align:center; padding:10px;"><b>REV-ERBβ - Nuclear Receptor Subfamily 1 Group D Member 2</b></td></tr>
<tr><th style="width:40%;">Gene Symbol</th><td>NR1D2</td></tr>
<tr><th>Alternate Names</th><td>REV-ERBβ, RORβ2</td></tr>
<tr><th>Chromosome</th><td>3p24.2</td></tr>
<tr><th>NCBI Gene ID</th><td><a href="https://www.ncbi.nlm.nih.gov/gene/10324" target="_blank">10324</a></td></tr>
<tr><th>OMIM</th><td><a href="https://www.omim.org/entry/603785" target="_blank">603785</a></td></tr>
<tr><th>Ensembl ID</th><td><a href="https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000150051" target="_blank">ENSG00000150051</a></td></tr>
<tr><th>UniProt ID</th><td><a href="https://www.uniprot.org/uniprot/Q14995" target="_blank">Q14995</a></td></tr>
<tr><th>Protein Length</th><td>478 amino acids</td></tr>
<tr><th>Subcellular Location</th><td>Nucleus</td></tr>
<tr><th>Associated Diseases</th><td>AD, PD, circadian rhythm disorders, metabolic disease</td></tr>
</table>
</div>

Overview

...

NR1D2 (Nuclear Receptor Subfamily 1 Group D Member 2)

Overview

NR1D2 (Nuclear Receptor Subfamily 1 Group D Member 2), also known as REV-ERBβ, is a nuclear receptor protein that functions as a transcriptional repressor and plays a critical role in the molecular circadian clock[@partch2014]. As the paralog of NR1D1 (REV-ERBα), NR1D2 shares structural and functional similarities but exhibits distinct expression patterns and biological roles. NR1D2 is encoded by the NR1D2 gene located on chromosome 3p24.2.

REV-ERBβ is a key component of the transcriptional-translational feedback loop that generates circadian rhythms in mammalian cells. Like its sibling protein REV-ERBα, NR1D2 represses the expression of core clock genes and controls a wide array of downstream target genes involved in metabolism, inflammation, and neuronal function[@sulli2019].

Structure and Function

Protein Architecture

NR1D2 is a 478-amino acid nuclear receptor with the typical domain structure of the nuclear receptor superfamily:

N-terminal domain (A/B domain): Transactivation domain

DNA-binding domain (C domain): Two C4-type zinc fingers for DNA binding

D domain (hinge region): Flexible linker allowing protein flexibility

Ligand-binding domain (E domain): HRE ligand binding and cofactor interaction

DNA Binding

NR1D2 binds to REV-ERB response elements (RRE) in target gene promoters:

Consensus sequence:
[A/T]A[AG]GTCA N AGGTCA

This is a direct repeat of the AGGTCA motif separated by one nucleotide (DR-1 type response element).

Transcriptional Repression

NR1D2 represses gene transcription through several mechanisms[@yin2018]:

Direct DNA binding: Binds to RRE in target promoters

Co-repressor recruitment: Recruits NCoR (Nuclear Receptor Co-Repressor) and HDAC3

Competition: Competes with activators for DNA binding sites

Chromatin remodeling: Creates repressive chromatin environment

NR1D2 Transcriptional Repression Mechanism

NR1D2 binds to REV-ERB response element (RRE)

│
▼

Recruits NCoR/HDAC3 co-repressor complex

│
▼

Histone deacetylation → chromatin compaction

│
▼

Blocks transcription factor access

│
▼

Reduced RNA polymerase II recruitment

│
▼

Repressed transcription of target genes

Biological Role in the Circadian Clock

The Molecular Circadian Clock

NR1D2 is an integral component of the core circadian clock machinery[@koike2012][@mohawk2012]:

Mermaid diagram (expand to render)

The circadian loop operates as follows:

CLOCK and BMAL1 form a heterodimer that activates transcription of NR1D1, NR1D2, PER, and CRY genes

As NR1D1/2 and PER/CRY proteins accumulate, they repress their own activation

The degradation of PER/CRY allows the cycle to restart

This ~24-hour oscillation drives daily rhythms in gene expression

Differences from NR1D1 (REV-ERBα)

While NR1D1 and NR1D2 share many functions, they have distinct characteristics:

| Feature | NR1D1 (REV-ERBα) | NR1D2 (REV-ERBβ) |
|---------|------------------|------------------|
| Gene | NR1D1 | NR1D2 |
| Chromosome | 17q11.2 | 3p24.2 |
| Expression pattern | Ubiquitous, high in liver | Higher in brain |
| Brain expression | Moderate | High in specific regions |
| Ligand | Heme | Heme |
| Target gene overlap | Partial | Partial |

Brain-Specific Functions

NR1D2 is particularly important in the central nervous system[@hudson2019]:

Neuronal survival: Protects neurons from oxidative stress

Synaptic function: Regulates synaptic plasticity genes

Glial function: Modulates astrocyte and microglial activity

Neuroprotection: Alters expression of neuroprotective genes

The NR1D2 protein (approximately 51 kDa) contains the characteristic nuclear receptor domain structure:

Alzheimer's Disease

NR1D2 is implicated in Alzheimer's disease through several mechanisms[@musiek2015][@zhang2021]:

Circadian disruption:

AD patients commonly exhibit disrupted circadian rhythms
Sleep-wake cycle disturbances precede cognitive decline
NR1D2 expression is altered in AD patient brains

Amyloid metabolism:

REV-ERB proteins regulate genes involved in APP processing
NR1D2 agonists may reduce amyloid burden
Effects on amyloid clearance mechanisms

Tau pathology:

Circadian genes regulate tau phosphorylation
NR1D2 may influence tau aggregation
Sleep disruption exacerbates tau pathology

Neuroinflammation:

NR1D2 modulates inflammatory gene expression
Circadian regulation of microglia function
Therapeutic potential of REV-ERB agonists

Parkinson's Disease

NR1D2 dysregulation contributes to PD pathogenesis[@musiek2020]:

Dopaminergic system:

NR1D2 regulates tyrosine hydroxylase expression
Altered circadian rhythm in dopaminergic neurons
Potential for chronotherapy approaches

Mitochondrial function:

NR1D2 controls mitochondrial biogenesis genes
Effects on PGC-1α pathway
Protection against oxidative stress

Sleep disorders:

PD patients commonly have circadian disruptions
REM sleep behavior disorder as early marker
Circadian-based therapeutic strategies

Metabolic Disease

NR1D2 plays important roles in metabolic regulation[@cho2020][@bugge2012][@solt2012]:

| Metabolic Process | NR1D2 Role |
|-------------------|------------|
| Lipid metabolism | Regulates fatty acid oxidation genes |
| Glucose homeostasis | Modulates insulin sensitivity |
| Adipogenesis | Controls adipocyte differentiation |
| Energy expenditure | Regulates thermogenesis genes |

Other Disorders

NR1D2 is implicated in:

Mood disorders: Circadian rhythm disturbances in depression/bipolar
Autism: Altered expression in ASD brain samples
Epilepsy: Circadian patterns in seizure frequency

Expression Pattern

NR1D2 exhibits distinct tissue and regional distribution:

| Tissue | Expression Level | Notes |
|--------|------------------|-------|
| Brain | High | Neurons in specific regions |
| Liver | Moderate | Metabolic tissues |
| Adipose | Moderate | Adipocytes |
| Heart | Low-moderate | Cardiac muscle |
| Muscle | Low | Skeletal muscle |
| Kidney | Low | Renal tissue |
| Lung | Low | Lung tissue |

Brain Regional Distribution

In the brain, NR1D2 shows higher expression than NR1D1 in several regions:

Hippocampus - CA1-CA3 pyramidal neurons, dentate gyrus
Suprachiasmatic nucleus - Master circadian pacemaker
Cerebral cortex - Layer-specific pyramidal neurons
Hypothalamus - Energy homeostasis centers
Cerebellum - Purkinje cells

Circadian Expression Pattern

NR1D2 expression follows a circadian pattern:

Peak expression: Late day/early evening
Nadir: Early morning
Rhythm amplitude: Tissue-specific
Entrainment: Light-dependent through SCN

Therapeutic Implications

REV-ERB Agonists

Synthetic REV-ERB agonists (e.g., SR9009, SR9011) activate both NR1D1 and NR1D2:

| Agonist | Specificity | Development Status |
|---------|-------------|-------------------|
| SR9009 | Mixed REV-ERBα/β | Research |
| SR9011 | Mixed REV-ERBα/β | Research |
| GSK4112 | REV-ERBα biased | Early research |
| SR8278 | REV-ERB antagonist | Research |

Therapeutic Applications

| Application | Mechanism | Stage |
|-------------|-----------|-------|
| Neuroprotection | Reduce neuroinflammation | Preclinical |
| Metabolic benefit | Improve mitochondrial function | Preclinical |
| Anti-aging | Enhance autophagy | Research |
| Sleep disorders | Reset circadian rhythm | Research |

Drug Development Strategies

Selective agonists: Develop NR1D2-specific agonists

Brain-penetrant compounds: Improve CNS delivery

Chronotherapy: Time administration to circadian phase

Combination therapy: Pair with other circadian modulators

Interaction Network

Core Clock Interactions

NR1D2 interacts with core clock components:

| Protein | Interaction |
|---------|-------------|
| CLOCK | Transcriptional activation |
| BMAL1 | Transcriptional activation |
| PER1/2 | Functional competition |
| CRY1/2 | Repression through competition |
| NR1D1 | Functional redundancy |

Co-factors and Partners

| Co-factor | Function |
|-----------|----------|
| NCoR | Corepressor recruitment |
| HDAC3 | Histone deacetylase |
| RORα/γ | Functional competition |
| PPARα | Metabolic cross-talk |

Target Genes

NR1D2 regulates numerous downstream genes:

BMAL1 (ARNTL) - Core clock gene
GLUT4 (SLC2A4) - Glucose transporter
FAS - Fatty acid synthase
UCP1 - Uncoupling protein 1
炎症基因 - Inflammatory mediators

NR1D2 is an integral component of the autoregulatory circadian feedback loop:

[NR1D1](/genes/nr1d1) - REV-ERBα (paralog)
[REV-ERBβ Protein](/proteins/nr1d2-protein)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Circadian Rhythm Disruption](/mechanisms/circadian-rhythm-disruption)
[Clock Genes in Neurodegeneration](/mechanisms/clock-genes-neurodegeneration)
[Nuclear Receptor Signaling](/mechanisms/nuclear-receptor-signaling)

F[NR1D1/REV-ERBα] -->|redundant repression| D
```

[NCBI Gene: NR1D2](https://www.ncbi.nlm.nih.gov/gene/10324)
[Ensembl: ENSG00000150051](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000150051)
[UniProt: Q14995](https://www.uniprot.org/uniprot/Q14995)
[GeneCards: NR1D2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=NR1D2)
[OMIM: 603785](https://www.omim.org/entry/603785)

[NR1D1](/genes/nr1d1)
[CLOCK](/proteins/clock)
[BMAL1](/proteins/arntl)
[PER proteins](/proteins/per)
[CRY proteins - Cryptochrome circadian clock proteins](/proteins)
[ROR proteins - ROR nuclear receptors](/proteins)
[Circadian rhythm and metabolism](/mechanisms/dian)

References

[Partch et al., Molecular architecture of the mammalian circadian clock (2014)](https://doi.org/10.1016/j.tcb.2014.04.007)

[Sulli et al., Interconnection between circadian clock and neurodegeneration (2019)](https://doi.org/10.1038/s41582-019-0221-1)

[Musiek & Holtzman, Disruption of circadian clocks and neurodegeneration (2015)](https://doi.org/10.1016/j.neurobiolaging.2015.04.008)

[Ramakrishnan et al., REV-ERBβ regulates neuronal gene expression and viability (2019)](https://doi.org/10.1007/s12031-019-01286-9)

[Cho et al., REV-ERBα and REV-ERBβ in metabolic disease (2020)](https://doi.org/10.1038/s41574-020-0347-2)

[Yin et al., REV-ERB nuclear receptors as therapeutic targets (2018)](https://doi.org/10.1038/nrd.2018.114)

[Koike et al., Transcriptional architecture of the mammalian circadian clock (2012)](https://doi.org/10.1101/sqb.2012.77.014787)

[Preitner et al., The orphan nuclear receptor REV-ERBα controls circadian transcription (2002)](https://doi.org/10.1016/S0092-8674(02)01125-4)

[Bugge et al., Rev-erbα and Rev-erbβ regulate circadian rhythms and metabolism (2012)](https://doi.org/10.1016/j.cell.2012.03.007)

[Solt et al., Regulation of circadian behavior and metabolism by REV-ERB (2012)](https://doi.org/10.1038/nature11048)

[Yang et al., Nuclear receptor REV-ERBα participates in circadian regulation of lipid metabolism (2006)](https://doi.org/10.1073/pnas.0603411103)

[Duez & Staels, REV-ERBα: an orphan nuclear receptor with a role in energy metabolism (2008)](https://doi.org/10.1161/CIRCRESAHA.108.173955)

[Bass & Takahashi, Circadian integration of metabolism and energetics (2011)](https://doi.org/10.1126/science.1195897)

[Mohawk, Green & Takahashi, Central and peripheral circadian clocks in mammals (2012)](https://doi.org/10.1146/annurev-neuro-060909-153128)

[Lundberg et al., Circadian clock genes and sleep-wake regulation in neurodegenerative disease (2019)](https://doi.org/10.1016/j.nbscr.2019.02.004)

[Hudson et al., REV-ERBβ as a therapeutic target in brain disorders (2019)](https://doi.org/10.1016/j.neuropharm.2019.107850)

[Zhang et al., Circadian clock and Alzheimer's disease (2021)](https://doi.org/10.1016/j.arr.2021.101358)

[Musiek et al., Circadian rhythm disruption in neurodegenerative disease (2020)](https://doi.org/10.1038/s41582-020-0334-7)

[Schibler et al., Molecular biology of circadian clocks (2015)](https://doi.org/10.1101/sqb.2015.80.027409)

[Dunmyre et al., Circadian clocks in brain function (2014)](https://pubmed.ncbi.nlm.nih.gov/25465032/)

[Youhou et al., Chronotherapy in neurodegenerative disease (2020)](https://doi.org/10.1016/j.jns.2020.117927)

📖 View canonical wiki page →

NR1D2 (Nuclear Receptor Subfamily 1 Group D Member 2)

NR1D2 (Nuclear Receptor Subfamily 1 Group D Member 2)

Overview

NR1D2 (Nuclear Receptor Subfamily 1 Group D Member 2)

Overview

Structure and Function

Protein Architecture

DNA Binding

Transcriptional Repression

Biological Role in the Circadian Clock

The Molecular Circadian Clock

Differences from NR1D1 (REV-ERBα)

Brain-Specific Functions

Alzheimer's Disease

Parkinson's Disease

Metabolic Disease

Other Disorders

Expression Pattern

Brain Regional Distribution

Circadian Expression Pattern

Therapeutic Implications

REV-ERB Agonists

Therapeutic Applications

Drug Development Strategies

Interaction Network

Core Clock Interactions

Co-factors and Partners

Target Genes

Related Pages

References